Bayer and MD Anderson collaborate on novel targeted cancer treatmentsBayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer. Share XBayer and MD Anderson collaborate on novel targeted cancer treatmentshttps://pharmaphorum.com/news/bayer-md-anderson-novel-targeted-cancer-treatments/